Saturday 17 October 2026
Export CRON’s income statement to Excel — free account
Cronos Group Inc.
CRON Healthcare Drug Manufacturers Specialty & Generic
Cronos Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $146.6 million, up 24.6% from fiscal 2024. In the quarter to June 2026, revenue grew 58.4%, EPS grew 190.0%, free cash flow grew 2,279.2% and total debt fell 4.71%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
3.22
0.02
+0.63%
Follow CRON
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 5 | 4 | 8 |
| 0.32% | (3.72%) | (3.07%) | 3.33% | ||
| 0.30% | (3.55%) | (2.95%) | 3.18% | ||
ROIC |
(4.30%) | (3.34%) | (2.98%) | (0.34%) | |
Return on Tangible Assets |
0.35% | (4.03%) | (3.34%) | 3.76% | |
Average Days of Receivables |
104.78 | 142.42 | 119.52 | 116.26 | |
Free Cash Flow per Share |
(0.01) | 0.00 | 0.07 | 0.13 | |
Free Cash Flow |
(5.74) | (0.19) | 26.19 | 49.44 | |
Capital Expenditures |
(27.49) | (26.06) | (12.67) | (10.61) | |
| Other line items | |||||
Cash ROIC |
(0.29%) | (0.01%) | 1.35% | 2.58% | |
Accounts Receivable Turnover |
3.71 | 3.40 | 3.83 | 3.71 | |
Accounts Payable Turnover |
8.62 | 5.86 | 9.24 | 6.56 | |
Inventory Turnover |
1.57 | 2.10 | 2.19 | 2.04 | |
Average Days of Payables |
52.89 | 50.68 | 41.08 | 65.59 | |
Days of Inventory on Hand |
234.48 | 203.56 | 194.48 | 198.39 | |
Tax Rate |
0.04 | (0.28) | (0.28) | 0.31 | |
Research and Development Expense of Revenue |
3.09% | 3.04% | 3.18% | 2.99% | |
Selling, General and Administrative Expense of Revenue |
53.49% | 48.31% | 46.08% | 42.10% | |
Share Based Compensation of Revenue |
6.04% | 4.81% | 3.93% | 3.60% | |
Interest Coverage |
— | — | 0.75 | — | |
Operating CF/Net income |
6.10 | (0.62) | (1.13) | 1.60 | |
Depreciation/Fixed assets |
0.09 | 0.10 | 0.11 | 0.10 | |
Capex/Depreciation |
(2.10) | (1.83) | (0.84) | (0.74) | |
Revenue per Share |
0.35 | 0.38 | 0.42 | 0.48 | |
Operating CF per Share |
0.06 | 0.07 | 0.10 | 0.16 | |
Capex per Share |
(0.07) | (0.07) | (0.03) | (0.03) | |
Capex to Sales |
0.21 | 0.18 | 0.08 | 0.06 |
Columns are period end dates